Advertisement
Home »

Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer.

Jun 12, 2023

ABOUT THE EXPERTS

  • G Villacampa

    SOLTI Breast Cancer Research Group, Barcelona, Spain; Oncology Data Science, Vall d’Hebron Institute of Oncology, Barcelona, Spain.

    N M Tung

    Beth Israel, Boston, USA.

    S Pernas

    Medical Oncology Department, Catalan Institute of Oncology, 08908, L’Hospitalet de Llobregat, Barcelona, Spain.

    L Paré

    Reveal Genomics, Barcelona, Spain.

    C Bueno-Muiño

    Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, 28009 Madrid, Spain.

    I Echavarría

    Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid, Spain.

    S López-Tarruella

    Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Geicam, Universidad Complutense, 28007 Madrid, Spain.

    M Roche-Molina

    Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

    M Del Monte-Millán

    Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid, Spain.

    M Marín-Aguilera

    Reveal Genomics, Barcelona, Spain.

    F Brasó-Maristany

    Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.

    A G Waks

    Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

    T Pascual

    SOLTI Breast Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.

    O Martínez-Sáez

    Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.

    A Vivancos

    Cancer Genomics Group, VHIO, Barcelona, Spain.

    P F Conte

    Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.

    V Guarneri

    Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.

    M Vittoria Dieci

    Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.

    G Griguolo

    Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.

    J Cortés

    International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona, Spain.

    A Llombart-Cussac

    Arnau de Vilanova Hospital, Universidad Católica de Valencia, Valencia, Spain.

    M Muñoz

    Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.

    M Vidal

    Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.

    B Adamo

    Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.

    A C Wolff

    Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, USA.

    A DeMichele

    Department of Oncology, University of Pennsylvania, Philadelphia, USA.

    P Villagrasa

    Reveal Genomics, Barcelona, Spain.

    J S Parker

    Lineberger Comprehensive Cancer Center; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.

    C M Perou

    Lineberger Comprehensive Cancer Center; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.

    A Fernandez-Martinez

    Lineberger Comprehensive Cancer Center; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.

    L A Carey

    Lineberger Comprehensive Cancer Center; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.

    E A Mittendorf

    Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA.

    M Martín

    Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Geicam, Universidad Complutense, 28007 Madrid, Spain.

    A Prat

    Reveal Genomics, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat.

    S M Tolaney

    Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: sara_tolaney@dfci.harvard.edu.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement